Loading
Latest filing published 17 Jul 2026 for Apotea AB (publ), €7,161. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Johan Lundgren is a declared insider of Apotea AB (publ), with filings sourced from Finansinspektionen. In total, 2 filings cover trades dated 17 July 2026.
Every open-market trade on record is a purchase: 2 purchases worth €21k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 17 July 2026: an open-market purchase of €7,161, in Apotea AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations